Pulmonology Lasers companies

  • Report ID: 3950
  • Published Date: Jul 03, 2025
  • Report Format: PDF, PPT

Key Pulmonology Lasers Market Players:

    The worldwide market of pulmonology lasers is very competitive, as the companies of the U.S., Germany, and Japan dominate it. Companies such as Olympus or Boston Scientific take the lead in terms of R&D and hospital partnerships to run clinical trials. Newer entrants like India and Malaysia are also making a name by providing affordable solutions. Acquisitions and local expansions are popular strategies, and market entry is influenced by regulatory approvals and certification. With the increasing demand in the Asia Pacific region, manufacturers are focusing on the scalable, fiber-delivered laser platform to cater to the large flow of patients in the developing world.

    • Olympus Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Boston Scientific Corporation
    • Lumenis
    • Biolitec AG
    • Cook Medical
    • KLS Martin Group
    • Quanta System
    • Richard Wolf GmbH
    • Alma Lasers
    • Asclepion Laser Technologies
    • Medtronic
    • Dornier MedTech
    • IRIDEX Corporation
    • Aloka Co., Ltd.
    • Jullundur Surgical Works

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In 2025, the industry size of Pulmonology Lasers was USD 7.20 billion.

The global Pulmonology Lasers market size was USD 6.50 billion in 2024 and is expected to reach USD 24.80 billion by the end of 2037, expanding at a CAGR of 10.80% during the forecast period, i.e., 2025-2037.

Key players in the market are BASF, Sinopec, Dow, SABIC, Formosa Plastics, Ineos, PetroChina, LyondellBasell Industries, LG Chem, ExxonMobil, Mitsubishi Chemical Group, Hengli Petrochemical, Linde, Air Liquide, Syngenta.

The lung cancer treatment segment of the pulmonology lasers market is projected to hold a dominant 40% revenue share by the end of 2037.

North America pulmonology lasers market is projected to account for a leading share of 37% by the end of 2037.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos